Year |
Citation |
Score |
2020 |
Smith MA, Chiang CC, Zerrouki K, Rahman S, White WI, Streicher K, Rees WA, Schiffenbauer A, Rider LG, Miller FW, Manna Z, Hasni S, Kaplan MJ, Siegel R, Sinibaldi D, ... ... Casey KA, et al. Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus. Scientific Reports. 10: 4462. PMID 32157125 DOI: 10.1038/S41598-020-60563-9 |
0.431 |
|
2019 |
Nicholson SM, Casey KA, Gunsior M, Drabic S, Iverson W, Cook H, Scott S, O'Day T, Karanth S, Dixit R, Ryan PC. The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys. British Journal of Pharmacology. PMID 31648370 DOI: 10.1111/Bph.14897 |
0.48 |
|
2019 |
Rahman S, Sagar D, Hanna RN, Lightfoot YL, Mistry P, Smith CK, Manna Z, Hasni S, Siegel RM, Sanjuan MA, Kolbeck R, Kaplan MJ, Casey KA. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 31040119 DOI: 10.1136/Annrheumdis-2018-214620 |
0.445 |
|
2019 |
Hudspeth K, Wang S, Wang J, Rahman S, Smith MA, Casey KA, Manna Z, Sanjuan M, Kolbeck R, Hasni S, Ettinger R, Siegel RM. Natural Killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in Systemic Lupus Erythematosus. Clinical and Experimental Immunology. PMID 30693467 DOI: 10.1111/Cei.13263 |
0.542 |
|
2019 |
Varkey R, Du Q, Karnell JL, Xiao X, Casey KA, Woods R, Rosenthal K, Wilson S, Dall'Acqua WF, Wu H, Herbst R, Ettinger R, Damschroder M. Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. Plos One. 14: e0211236. PMID 30682117 DOI: 10.1371/Journal.Pone.0211236 |
0.454 |
|
2018 |
Casey KA, Guo X, Smith MA, Wang S, Sinibaldi D, Sanjuan MA, Wang L, Illei GG, White WI. Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE. Lupus Science & Medicine. 5: e000286. PMID 30538817 DOI: 10.1136/Lupus-2018-000286 |
0.316 |
|
2017 |
Gerner MY, Casey KA, Kastenmuller W, Germain RN. Dendritic cell and antigen dispersal landscapes regulate T cell immunity. The Journal of Experimental Medicine. PMID 28847868 DOI: 10.1084/Jem.20170335 |
0.798 |
|
2017 |
White W, Casey K, Smith M, Wang L, Sinbaldi D, Sanjuan M, Illei G. SAT0220 Effects of type I interferon inhibition on blood leukocyte subsets in patients treated in a phase IIB clinical study of anifrolumab in systemic lupus erythematosus (SLE) Annals of the Rheumatic Diseases. 76: 856-857. DOI: 10.1136/Annrheumdis-2017-Eular.3833 |
0.589 |
|
2016 |
Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. PMID 27096360 DOI: 10.1038/Nature17655 |
0.333 |
|
2016 |
Schenkel JM, Fraser KA, Casey KA, Beura LK, Pauken KE, Vezys V, Masopust D. IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 27001957 DOI: 10.4049/Jimmunol.1502337 |
0.676 |
|
2016 |
Sanjuan M, Henault J, Riggs J, Karnell J, Liarski V, Shirinian L, Xu L, Casey K, Smith M, Khatry D, Clarke L, Herbst R, Ettinger R, Petri M, Clark M, et al. AB0146 Self-Reactive IGE Exacerbates Interferon Responses Associated with Autoimmunity Annals of the Rheumatic Diseases. 75: 946.2-947. DOI: 10.1136/Annrheumdis-2016-Eular.3791 |
0.362 |
|
2015 |
Henault J, Riggs JM, Karnell JL, Liarski VM, Li J, Shirinian L, Xu L, Casey KA, Smith MA, Khatry DB, Izhak L, Clarke L, Herbst R, Ettinger R, Petri M, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nature Immunology. PMID 26692173 DOI: 10.1038/Ni.3326 |
0.38 |
|
2012 |
Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, Vezys V, Masopust D. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. Journal of Immunology (Baltimore, Md. : 1950). 188: 4866-75. PMID 22504644 DOI: 10.4049/Jimmunol.1200402 |
0.631 |
|
2010 |
Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, Wang J, Casey KA, Barber DL, Kawamura KS, Fraser KA, Webby RJ, Brinkmann V, Butcher EC, Newell KA, et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. The Journal of Experimental Medicine. 207: 553-64. PMID 20156972 DOI: 10.1084/Jem.20090858 |
0.524 |
|
2009 |
Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. Programming for CD8 T cell memory development requires IL-12 or type I IFN. Journal of Immunology (Baltimore, Md. : 1950). 182: 2786-94. PMID 19234173 DOI: 10.4049/Jimmunol.0803484 |
0.771 |
|
2009 |
Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature. 457: 196-9. PMID 19005468 DOI: 10.1038/Nature07486 |
0.679 |
|
2009 |
Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Vezys et al. reply Nature. 459. DOI: 10.1038/Nature08092 |
0.679 |
|
2008 |
Gerner MY, Casey KA, Mescher MF. Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 155-64. PMID 18566380 DOI: 10.4049/Jimmunol.181.1.155 |
0.804 |
|
2008 |
Gerner MY, Casey KA, Mescher MF. Dendritic cell tumor‐antigen processing and activation of tumor‐specific T cells The Faseb Journal. 22: 527-527. DOI: 10.1096/Fasebj.22.2_Supplement.527 |
0.757 |
|
2007 |
Casey KA, Mescher MF. IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. Journal of Immunology (Baltimore, Md. : 1950). 178: 7640-8. PMID 17548600 DOI: 10.4049/Jimmunol.178.12.7640 |
0.765 |
|
2007 |
Mescher MF, Agarwal P, Casey KA, Hammerbeck CD, Xiao Z, Curtsinger JM. Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. Seminars in Immunology. 19: 153-61. PMID 17382557 DOI: 10.1016/J.Smim.2007.02.007 |
0.769 |
|
2006 |
Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunological Reviews. 211: 81-92. PMID 16824119 DOI: 10.1111/J.0105-2896.2006.00382.X |
0.607 |
|
Show low-probability matches. |